Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan plus Amlodipine in Hypertension Non-responders
NCT00550953Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, amlodipine in essential hypertension, sponsored by Boehringer Ingelheim. Started Oct 2007; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00550953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550953.